4//SEC Filing
LEA LEIV 4
Accession 0001567619-21-017014
CIK 0001626971other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:59 PM ET
Size
5.5 KB
Accession
0001567619-21-017014
Insider Transaction Report
Form 4
LEA LEIV
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-09-09+160,000→ 160,000 totalExercise: $2.60Exp: 2031-09-09→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from September 9, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Corvus Pharmaceuticals, Inc.
CIK 0001626971
Entity typeother
Related Parties
1- filerCIK 0000939012
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:59 PM ET
- Size
- 5.5 KB